Latest News

This KEYTRUDA Combination Is the First Immunotherapy Regimen Approved for High-Risk Early-Stage Triple-Negative Breast Cancer (TNBC)

Information about the COVID-19 pandemic for people diagnosed with, or at high risk for, ovarian/endometrial cancer

Working with the foundation entails many rewarding experiences and Sandi keeps her fondest memories with ABCF close to her heart.